Exploitation of the Low Fidelity of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase and the Nucleotide Composition Bias in the HIV-1 Genome To Alter the Drug Resistance Development of HIV

Benzer Materyaller

• Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
  Yazar:: Balzarini, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors
  Yazar:: Boyer, Paul L., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
  Yazar:: Balzarini, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1994)
• Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy.
  Yazar:: Balzarini, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside Inhibitors
  Yazar:: Ceccherini-Silberstein, Francesca, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)